Commission presents Strategic Approach to Pharmaceuticals in the Environment

The European Commission has adopted a Communication outlining a set of actions addressing the “Strategic Approach to Pharmaceuticals in the Environment”. The plan that the Commission presented on March 11th, identifies six action areas concerning all stages of the pharmaceutical life cycle, where improvements can be made.

read more


EU Health Summit – Recommendations for a healthier Europe

EFCG is a proud member of the coalition of associations behind the high-level EU health Summit that took place last November 29th in Brussels. This multi-stakeholder event, …

read more

EMA Booklet – From lab to patient

 EMA has published a booklet describing the journey of a medicine for human use authorised through EMA, from initial research to discussions on patient access to medicines across the EU: From laboratory to patient: the journey of a centrally authorised medicine – Link.

SPC manufacturing waiver

On January 23rd, 2019, the European Parliament’s JURI Committee voted its amendments to the Commission’s proposal amending Regulation (EC 469/2009) concerning the supplementary protection certificate for medicinal products. For more information, download our briefing note. Download.